China SXT Pharmaceuticals (SXTC) Change in Receivables (2018 - 2019)

China SXT Pharmaceuticals (SXTC) recorded quarterly Change in Receivables of $4.6 million in Q3 2019, up 9.27% quarter-over-quarter from $4.2 million in Q1 2019, and up 17.44% on a YoY basis from $3.9 million in Q3 2018.

China SXT Pharmaceuticals (SXTC) Change in Receivables (2018 - 2019) Analysis & Trends

China SXT Pharmaceuticals' Change in Receivables history runs 2 years deep, the most recent figure standing at $4.6 million for Q3 2019.

  • In Q3 2019, Change in Receivables rose 17.44% year-over-year to $4.6 million; the TTM figure through Sep 2019 stood at $4.6 million (up 17.44% YoY), while the FY2025 annual figure was $257085.0, down 20.02% from the prior year.
  • Change in Receivables was $4.6 million for Q3 2019 at China SXT Pharmaceuticals, up from $4.2 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $4.6 million in Q3 2019 to a low of $2.6 million in Q1 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -78.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 106.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -38.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 81.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 23.22 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 116.25 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.23 Mn
10 China SXT Pharmaceuticals 187.96 Mn 166.77 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2019 4.57 Mn
Sep 30, 2019 4.57 Mn
Mar 31, 2019 4.18 Mn
Mar 31, 2019 4.18 Mn
Sep 30, 2018 3.89 Mn
Sep 30, 2018 3.89 Mn
Mar 31, 2018 2.60 Mn
Mar 31, 2018 2.60 Mn